Work

A Vaxfectin®-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes

Year: 2012

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2012.09.057

Authors: Ronald L. Veselenak, Mark Shlapobersky, Richard B. Pyles, Qun Wei, Sean M. Sullivan, Nigel Bourne

Institutions: The University of Texas Medical Branch at Galveston, Vical (United States)

Language: English

Topic: Herpesvirus Infections and Treatments

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: GlaxoSmithKline, National Institutes of Health, National Institute of Allergy and Infectious Diseases

Award: Herpes Simplex Immunotherapeutic Vaccine

OpenAlex ID: W2140882027

FWCI: 3.831

Cites: 37

Cited by: 58

Related to: 10